Assessment of Bezlotoxumab Immunogenicity.
Montgomery DL, Matthews RP, Yee KL, Tobias LM, Dorr MB, Wrishko RE.
Montgomery DL, et al. Among authors: wrishko re.
Clin Pharmacol Drug Dev. 2020 Apr;9(3):330-340. doi: 10.1002/cpdd.729. Epub 2019 Aug 14.
Clin Pharmacol Drug Dev. 2020.
PMID: 31411386